COVID-19 is an infectious respiratory disease caused by a coronavirus known as SARS-CoV-2, which is spread through the air. If the infection grows serious, patients may require hospitalization for critical care and support, which may include mechanical ventilation.
The pandemic-inducing virus also includes the testing of drugs used to treat other diseases, such as chloroquine, which is used to treat malaria, and hydroxychloroquine 200 (HCQS 200), which is used to treat rheumatic diseases such as rheumatoid arthritis and systemic lupus erythematosus. It was the authors’ goal to gather evidence about the effects of these drugs in treating people who were sick with the disease, preventing the disease in people who were at risk of getting the disease, such as health workers, and preventing the disease in people who had been exposed to the virus and developed it.
Uses of Hydroxychloroquine 200 (HCQS 200) in the Treatment of Covid 19
In patients with the virus who are being treated with hydroxychloroquine or chloroquine, which is frequently used in combination with azithromycin and other QT-prolonging medications, the FDA has received reports of significant heart rhythm abnormalities. We’re also aware of a rise in the usage of these medications through outpatient prescriptions, which is concerning. As a result, we would want to warn healthcare professionals and patients about the known dangers connected with both hydroxychloroquine and chloroquine use in general. The hazards linked with using hydroxychloroquine and chloroquine for the virus will be investigated further, and we will disseminate any new information to the public as soon as it becomes available.
Efficacy of Hydroxychloroquine 200 in COVID-19
The use of hydroxychloroquine 200 for the treatment or prevention of the virus has not been proven to be safe and effective. Through an Emergency Use Authorization, we permitted their temporary use during the pandemic-inducing virus for the treatment of the virus in hospitalized patients when clinical trials were not accessible or participation was not practicable (EUA).
Medical supplies for the hydroxychloroquine EUA are sourced from the Strategic National Stockpile, which serves as a national reserve for important medical supplies that can be used in public health emergencies like cholera outbreaks. The purpose of this safety message is to remind physicians and the general public of the risk information contained in the hydroxychloroquine healthcare provider fact sheets, which were required by the European Union’s Anti-Doping Agency.
Hydroxychloroquine 200 have the potential to produce aberrant cardiac rhythms such as QT interval lengthening and ventricular tachycardia, which is a dangerously rapid heart rate. These hazards may be exacerbated when these medications are taken in conjunction with other medications that have been shown to lengthen the QT interval, such as the antibiotic azithromycin, which is also being used in some COVID-19 patients without FDA authorization for the condition in question. It is likely that patients who also have other health concerns, such as heart or renal disease, will have an increased chance of developing these heart problems while taking these medications so it is always suggested to take Hydroxychloroquine 200 only if the doctor prescribes.
You can buy Hydroxychloroquine 200 tablets from Unitedmedicines.com in USA, UK & Australia at low price.